Band, C J <br/><br/>
Early signaling events triggered by peroxovanadium [bpV(phen)] are insulin receptor kinase (IRK)-dependent: specificity of inhibition of IRK-associated protein tyrosine phosphatase(s) by bpV(phen).  [electronic resource] 

 -  Molecular endocrinology (Baltimore, Md.)  Dec 1997 
 - 1899-910 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>0888-8809 
<br/><br/><label>Standard No.: </label>10.1210/mend.11.13.0041  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Animals<br/>Carcinoma, Hepatocellular<br/>Dose-Response Relationship, Drug<br/>Drug Synergism<br/>Enzyme Activation--drug effects<br/>Humans<br/>Insulin--pharmacology<br/>Insulin Receptor Substrate Proteins<br/>Intracellular Signaling Peptides and Proteins<br/>Liver Neoplasms<br/>Organometallic Compounds--pharmacology<br/>Phenanthrolines--pharmacology<br/>Phosphatidylinositol 3-Kinases--drug effects<br/>Phosphoproteins--drug effects<br/>Phosphorylation--drug effects<br/>Precipitin Tests<br/>Protein Tyrosine Phosphatase, Non-Receptor Type 11<br/>Protein Tyrosine Phosphatase, Non-Receptor Type 6<br/>Protein Tyrosine Phosphatases--antagonists & inhibitors<br/>Rats<br/>Receptor, Insulin--antagonists & inhibitors<br/>Recombinant Fusion Proteins<br/>SH2 Domain-Containing Protein Tyrosine Phosphatases<br/>Signal Transduction--drug effects<br/>Substrate Specificity--drug effects<br/>Tumor Cells, Cultured<br/>Tyrosine--metabolism<br/>src Homology Domains--drug effects